MDK and glioblastoma: For EGFRvIII(+) GBM patient single-cell data (Fig. S2B), the pattern analysis results showed that in the outgoing pattern analysis, tumor cells dominated Pattern3, with the MDK signaling pathway being the most active in Pattern3, followed by the PTN and SPP1 signaling pathways.